MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0072066
Aristo Raw Pharma Private Limited
Aristo Raw Pharma Private Limited - trading in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹12.48 Cr
▼ 1% YoY
Net loss · FY 2025
₹5.16 Lakh
Net margin -0.4%
EBITDA · FY 2025
₹9.37 Lakh
EBITDA margin 0.8%
Authorised capital
₹21 Lakh
Registered with MCA
Paid-up capital
₹1.04 Lakh
Issued & subscribed
Satisfied charges
₹1 Cr
No open charges
Company age
30 yrs
Est. 1996
Directors on board
2
As per MCA filings
About Aristo Raw Pharma Private Limited
Data last updated:
Aristo Raw Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 26 July 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH1996PTC101415. Its GSTIN is 27AACCA5644H1ZQ (Maharashtra).
The company has an authorised share capital of ₹21 Lakh and a paid-up capital of ₹1.04 Lakh. It is led by directors Chirag Bharat Parekh and Bharat Jayantilal Parekh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.48 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net loss of ₹5.16 Lakh (net margin -0.4%) and EBITDA of ₹9.37 Lakh (EBITDA margin 0.8%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 4% over five years.
As per MCA filings, the company has satisfied charges of ₹1 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 2 cases are pending.
Aristo Raw Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0072066). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51397MH1996PTC101415
Registration Number 101415
Incorporation Date 26 July 1996
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0072066
Recognitions & Rankings of Aristo Raw Pharma
Contact details
Aristo Raw Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOffice No. E1 – 502 Built – Up 253 Square Feet, 5th Floor Kailas Esplanade Complex L.B.S Road Ghatkopar West, Mumbai, Maharashtra, India – 400086
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Aristo Raw Pharma Private Limited, buy the company report.
Comprehensive company report
Aristo Raw Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aristo Raw Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aristo Raw Pharma Private Limited, buy the company report.
Financials of Aristo Raw Pharma Private Limited
FY 2025 filings availableAristo Raw Pharma Private Limited reported revenue of ₹12.48 Cr (down 1% YoY) for FY 2025.
Revenue · FY 2025
₹12.48 Cr ▼ 1%
Net loss · FY 2025
₹5.16 Lakh margin -0.4%
EBITDA · FY 2025
₹9.37 Lakh margin 0.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▼ 6%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 124%
3 years · compounded
▼ 34%
5 years · compounded
▼ 24%
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 1% fall in the latest year. EBITDA rose 124% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.37 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aristo Raw Pharma Private Limited, buy the company report.
Board of directors of Aristo Raw Pharma Private Limited
Aristo Raw Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chirag Bharat Parekh | Director | 01 Nov 2017 | 8 Years 11 Months | Current |
| Bharat Jayantilal Parekh | Director | 01 May 1999 | 27 Years 5 Months | Current |
Peer comparison
Aristo Raw Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| R.M.V. Distributors Private Limited | ₹12.49 Cr (FY 2024) | 2.0% | Uttar Pradesh, India | |||
| Aristo Raw Pharma Private Limitedthis company | ₹12.48 Cr (FY 2025) | -₹5.16 Lakh | -0.4% | -1.0% | Mumbai, Maharashtra, India | |
| Vardhman Drugs Private Limited | ₹12.46 Cr (FY 2024) | 21.0% | Meerut, Uttar Pradesh, India | |||
| Prism Medical and Pharmacy Private Limited | ₹12.45 Cr (FY 2025) | 3.0% | Raipur, Chhattisgarh, India |
To see the full peer comparison of Aristo Raw Pharma Private Limited, buy the company report.
Auditor
Aristo Raw Pharma Private Limited is audited by S. V. KAMATH AND CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S. V. KAMATH AND CO | FY 2017 | 043551 |
Shareholding
The shareholding of Aristo Raw Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Aristo Raw Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jan 2009 | 10139109 | 3I Infotech Trusteeship Services Limited | ₹1 Cr | Satisfied |
To see the full charge records of Aristo Raw Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Aristo Raw Pharma Private Limited has 5 court cases on record: 3 filed by Aristo Raw Pharma, 2 filed against it. 2 cases are pending and 3 are disposed.
Total cases
5
Filed by the company
3
Filed against the company
2
Pending
2
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 2 | 2 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Cheque dishonour complaint | Filed against the company by Sterile India Private Limited | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against Jaywin Rededies Pvt. Ltd. and 2 others | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed by the company against Ms. Medirose Drugs and Pharmaceuticals and Ors and 4 others | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed by the company against Jaywin Rededies Pvt. Ltd. Ors and 2 others | Disposed |
To see the full case history of Aristo Raw Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aristo Raw Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aristo Raw Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCA5644H1ZQ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aristo Raw Pharma Private Limited, buy the company report.
Recent activity
Aristo Raw Pharma Private Limited has 7 board changes on record since 1999: 3 appointments and 4 cessations. The latest: Lata Parekh ceased to be Director on 31 Mar 2023.
AGM
Aristo Raw Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aristo Raw Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Lata Parekh ceased to be Director.
Ceased
Varsha Anil Parekh ceased to be Director.
Ceased
Anil Jayantilal Parekh ceased to be Additional Director.
Ceased
Chirag Bharat Parekh ceased to be Additional Director.
Appointed
Anil Jayantilal Parekh was appointed as Director.
Appointed
Chirag Bharat Parekh was appointed as Director.
Charges
A charge registered on 20 Jan 2009 via Charge ID 10139109 with 3I Infotech Trusteeship Services Limited was fully satisfied on 13 Jul 2011.
Charges
A charge with 3I Infotech Trusteeship Services Limited amounted to Rs. 100.00 Lakh with Charge ID 10139109 was registered on 20 Jan 2009.
Appointed
Bharat Jayantilal Parekh was appointed as Director.
Incorporation
26 Jul 1996
Aristo Raw Pharma Private Limited was registered on 26 Jul 1996 with Roc Mumbai I & aged 30 years 3 months as per MCA records.
Frequently asked questions
Aristo Raw Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 26 July 1996 (30+ years old) and is registered under CIN U51397MH1996PTC101415.
Aristo Raw Pharma has 2 current directors:
- Chirag Bharat Parekh - Director
- Bharat Jayantilal Parekh - Director
The latest financial statements of Aristo Raw Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aristo Raw Pharma is 27AACCA5644H1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aristo Raw Pharma is U51397MH1996PTC101415. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aristo Raw Pharma has 5 court cases on record: 3 filed by the company and 2 filed against it. 2 are pending.
Aristo Raw Pharma was incorporated on 26 July 1996, making it 30+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Aristo Raw Pharma by revenue are R.M.V. Distributors Private Limited, Vardhman Drugs Private Limited, Prism Medical and Pharmacy Private Limited, all in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Lata Parekh ceased to be Director on 31 Mar 2023. Varsha Anil Parekh ceased to be Director on 31 Mar 2023. Anil Jayantilal Parekh ceased to be Additional Director on 29 Sep 2018. Aristo Raw Pharma has 7 board changes on record in total.
Yes, Aristo Raw Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0072066).
The registered office of Aristo Raw Pharma is at Office No. E1 – 502 Built – Up 253 Square Feet, 5th Floor Kailas Esplanade Complex L.B.S Road Ghatkopar West, Mumbai, Maharashtra, India – 400086.